The MarketWatch News Department was not involved in the creation of this content.
Sep 14, 2021 (Baystreet.ca via COMTEX) -- The cannabis boom is thriving in Canada. So much so, the industry is expected to balloon from $31.5 billion in 2020 revenue to $10.1 billion by 2025. Helping, sales growth for vape pens is expected to run from 3.9% in 2019 to more than 18% by 2022. Edibles are expected to increase from 1% sales growth to 9%, as topicals run from 0% to about 1%. In addition, sales are seeing higher highs. In June 2021, Canadian cannabis sales were up 59% in June to $319 million. That was after 68% cannabis sales growth for May 2021. One of the companies benefiting from that wild growth is Ayurcann Holdings Corp. (CSE: AYUR)(FSE:3ZQ0), a leading post-harvest solution provider with a focus on providing. and creating custom processes and pharma grade Products for the adult use and medical cannabis industry in Canada.
In addition, some of the other cannabis stocks you may want to keep an eye on include Kiaro Holdings Corp. (TSXV:KO)(OTC:KIARF), Auxly Cannabis (TSXV:XLY)(OTC:CBWTF), Entourage Health Corp. (TSXV:ENTG)(OTC:ETRGF), and Canopy Growth Corp. (NASDAQ:CGC)(TSX:WEED).